110 related articles for article (PubMed ID: 38171965)
1. Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.
Justice AC; Tate JP; Howland F; Gaziano JM; Kelley MJ; McMahon B; Haiman C; Wadia R; Madduri R; Danciu I; Leppert JT; Leapman MS; Thurtle D; Gnanapragasam VJ
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38171965
[TBL] [Abstract][Full Text] [Related]
2. Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration.
McGinnis KA; Justice AC; Marconi VC; Rodriguez-Barradas MC; Hauser RG; Oursler KK; Brown ST; Bryant KJ; Tate JP;
Front Med (Lausanne); 2023; 10():1342466. PubMed ID: 38356736
[TBL] [Abstract][Full Text] [Related]
3. Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality Among People With Human Immunodeficiency Virus in North America.
McGinnis KA; Justice AC; Moore RD; Silverberg MJ; Althoff KN; Karris M; Lima VD; Crane HM; Horberg MA; Klein MB; Gange SJ; Gebo KA; Mayor A; Tate JP;
Clin Infect Dis; 2022 Aug; 75(2):297-304. PubMed ID: 34609485
[TBL] [Abstract][Full Text] [Related]
4. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
[TBL] [Abstract][Full Text] [Related]
5. Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer.
Rasmussen KM; Patil V; Li C; Yong C; Appukkuttan S; Grossman JP; Jhaveri J; Halwani AS
JAMA Netw Open; 2023 Oct; 6(10):e2337272. PubMed ID: 37819658
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.
Daskivich TJ; Kwan L; Dash A; Greenfield S; Litwin MS
Eur Urol; 2014 Dec; 66(6):1002-9. PubMed ID: 24924554
[TBL] [Abstract][Full Text] [Related]
8. The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.
Gnanapragasam VJ; Bratt O; Muir K; Lee LS; Huang HH; Stattin P; Lophatananon A
BMC Med; 2018 Feb; 16(1):31. PubMed ID: 29490658
[TBL] [Abstract][Full Text] [Related]
9. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and competing risks for mortality in men with prostate cancer.
Daskivich TJ; Chamie K; Kwan L; Labo J; Dash A; Greenfield S; Litwin MS
Cancer; 2011 Oct; 117(20):4642-50. PubMed ID: 21480201
[TBL] [Abstract][Full Text] [Related]
11. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
Dell'Oglio P; Bishr M; Boehm K; Trudeau V; Larcher A; Tian Z; Sosa J; Moschini M; Saad F; Capitanio U; Briganti A; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol Focus; 2018 Dec; 4(6):834-841. PubMed ID: 28753853
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.
Dess RT; Suresh K; Zelefsky MJ; Freedland SJ; Mahal BA; Cooperberg MR; Davis BJ; Horwitz EM; Terris MK; Amling CL; Aronson WJ; Kane CJ; Jackson WC; Hearn JWD; Deville C; DeWeese TL; Greco S; McNutt TR; Song DY; Sun Y; Mehra R; Kaffenberger SD; Morgan TM; Nguyen PL; Feng FY; Sharma V; Tran PT; Stish BJ; Pisansky TM; Zaorsky NG; Moraes FY; Berlin A; Finelli A; Fossati N; Gandaglia G; Briganti A; Carroll PR; Karnes RJ; Kattan MW; Schipper MJ; Spratt DE
JAMA Oncol; 2020 Dec; 6(12):1912-1920. PubMed ID: 33090219
[TBL] [Abstract][Full Text] [Related]
13. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
[TBL] [Abstract][Full Text] [Related]
14. Veterans Aging Cohort Study (VACS): Overview and description.
Justice AC; Dombrowski E; Conigliaro J; Fultz SL; Gibson D; Madenwald T; Goulet J; Simberkoff M; Butt AA; Rimland D; Rodriguez-Barradas MC; Gibert CL; Oursler KA; Brown S; Leaf DA; Goetz MB; Bryant K
Med Care; 2006 Aug; 44(8 Suppl 2):S13-24. PubMed ID: 16849964
[TBL] [Abstract][Full Text] [Related]
15. Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.
Beckmann K; Garmo H; Adolfsson J; Bosco C; Johansson E; Robinson D; Holmberg L; Stattin P; Van Hemelrijck M
Eur Urol; 2019 Apr; 75(4):676-683. PubMed ID: 30497883
[TBL] [Abstract][Full Text] [Related]
16. Do functional status and Medicare claims data improve the predictive accuracy of an electronic health record mortality index? Findings from a national Veterans Affairs cohort.
Deardorff WJ; Jing B; Jeon SY; Boscardin WJ; Lee AK; Fung KZ; Lee SJ
BMC Geriatr; 2022 May; 22(1):434. PubMed ID: 35585537
[TBL] [Abstract][Full Text] [Related]
17. Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 - 2018.
Vesterager JD; Madsen M; Hjelholt TJ; Kristensen PK; Pedersen AB
Clin Epidemiol; 2022; 14():275-287. PubMed ID: 35299726
[TBL] [Abstract][Full Text] [Related]
18. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
19. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
